Exicure Inc. (XCUR)

Name: Exicure Inc. (XCUR) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Exicure Inc. (XCUR)

Stock Card

$1.29

$-0.12 (-8.51%)

As on 28-Aug-2026 16:03EDT

Market cap

$8 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

7.7

Div. Yield

0 %

Exicure (XCUR) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 1.29 High: 1.40

52 Week Range

Low: 1.05 High: 9.48

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-1.7 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-0
Debt to Equity

0
Book Value

$--
EPS

$-1.3
Face value

--
Shares outstanding

6,545,995

8 Years Aggregate

CFO

$-164.96 Mln

EBITDA

$-169.96 Mln

Net Profit

$-173.68 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Exicure (XCUR)	-76.2	-26.3	-53.8	-77.4	-32.5	-63.7	--
BSE Sensex	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
Exicure (XCUR)	-60.4	365.5	-49.6	-81.0	-88.6	-38.1	-19.2
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Exicure (XCUR)	1.3	7.5	0.0	-8.3	--	-337.9	--	7.7
Arrowhead Pharmaceuticals (ARWR)	84.9	12,304.7	669.5	-320.0	-0.8	-71.1	--	26.4
Ascendis Pharma A/S - ADR	246.7	16,614.0	1,054.4	755.9	5.7	--	19.4	10.1
Cytokinetics Inc (CYTK)	72.3	10,682.6	71.0	-894.0	-1,175.8	--	--	60.3
Exelixis (EXEL)	54.2	13,400.0	2,435.9	860.6	31.0	43	17	7.3
Halozyme Therapeutics (HALO)	105.3	12,277.1	1,663.7	413.6	36.3	430	31.2	83.9
Krystal Biotech (KRYS)	350.5	10,258.4	440.5	241.5	33.4	18.7	42.2	7.3
Madrigal Pharmaceuticals (MDGL)	534.5	11,938.8	1,283.9	-325.1	-19.0	-57.7	--	22.9
Medpace Holdings (MEDP)	603.9	17,326.2	2,782.3	491.5	21.1	110.1	36.5	39.4
Praxis Precision MedicinesÂ Inc (PRAX)	348.4	10,496.2	0.0	-339.1	--	-30.6	--	7.6

Shareholding Pattern

View Details

About Exicure (XCUR)

Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore... combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California. Read more

CEO & Director

Mr. Paul Kang
CEO & Director

Mr. Paul Kang
Headquarters

Redwood City, CA
Website

https://www.exicuretx.com

FAQs for Exicure (XCUR)

What is the current share price of Exicure Inc (XCUR) Today?

The share price of Exicure Inc (XCUR) is $1.29 (NASDAQ) as of 28-Aug-2026 16:03 EDT. Exicure Inc (XCUR) has given a return of -32.53% in the last 3 years.

What is the current PB & PE ratio of Exicure Inc (XCUR)?

Since, TTM earnings of Exicure Inc (XCUR) is negative, P/E ratio is not available.
The P/B ratio of Exicure Inc (XCUR) is 7.71 times as on 21-Aug-2026, a 44 premium to its peers’ median range of 5.35 times.

PE & PB ratio at the end of financial year.